Protection against Osteoporosis by Active Immunization with TRANCE/RANKL Displayed on Virus-Like Particles

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Journal of Immunology

• Publication date

  2005-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.4049/jimmunol.175.9.6211PMID 16237119
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Therapeutic vaccination for chronic diseases: a new class of drugs in sight

  2004cited by this paper
• A Phase I study of AMGN‐0007, a recombinant osteoprotegerin construct, in patients with multiple myeloma or breast carcinoma related bone metastases

  2003cited by this paper
• Subacute meningoencephalitis in a subset of patients with AD after Aβ42 immunization

  2003cited by this paper
• Virus-Like Particles as a Modular System for Novel Vaccines

  2003cited by this paper
• Pubertal Changes in Biochemical Markers of Growth

  2003cited by this paper
• Defective thymocyte apoptosis and accelerated autoimmune diseases in TRAIL−/− mice

  2003cited by this paper
• Neuropathology of human Alzheimer disease after immunization with amyloid-β peptide: a case report

  2003cited by this paper
• Biology of the TRANCE axis.

  2003cited by this paper
• Generation of antibodies specific for β-amyloid by vaccination of patients with Alzheimer disease

  2002cited by this paper
• Determinants of Autoantibody Induction by Conjugated Papillomavirus Virus-Like Particles

  2002cited by this paper
• Tumor necrosis factor alpha-mediated joint destruction is inhibited by targeting osteoclasts with osteoprotegerin.

  2002cited by this paper
• Sex steroids and the construction and conservation of the adult skeleton.

  2002cited by this paper
• Humoral immunity and long-lived plasma cells.

  2002cited by this paper
• Critical Role for Activation of Antigen-Presenting Cells in Priming of Cytotoxic T Cell Responses After Vaccination with Virus-Like Particles1

  2002cited by this paper
• RANK-L and RANK: T cells, bone loss, and mammalian evolution.

  2002cited by this paper
• A molecular assembly system that renders antigens of choice highly repetitive for induction of protective B cell responses.

  2002cited by this paper
• Osteoprotegerin diminishes advanced bone cancer pain.

  2001cited by this paper
• Active Vaccination Against IL-5 Bypasses Immunological Tolerance and Ameliorates Experimental Asthma1

  2001cited by this paper
• Emerging therapies in osteoporosis.

  2001cited by this paper
• The Effect of a Single Dose of Osteoprotegerin in Postmenopausal Women

  2001cited by this paper
• Conjugation of a self-antigen to papillomavirus-like particles allows for efficient induction of protective autoantibodies.

  2001cited by this paper
• Mutilation of RNA phage Qβ virus‐like particles: from icosahedrons to rods

  2000cited by this paper
• Active immunization with angiotensin I peptide analogue vaccines selectively reduces the pressor effects of exogenous angiotensin I in conscious rats

  2000cited by this paper
• Regulation of Peripheral Lymph Node Genesis by the Tumor Necrosis Factor Family Member Trance

  2000cited by this paper
• The osteoclast differentiation factor osteoprotegerin-ligand is essential for mammary gland development.

  2000cited by this paper
• Osteoprotegerin Reverses Osteoporosis by Inhibiting Endosteal Osteoclasts and Prevents Vascular Calcification by Blocking a Process Resembling Osteoclastogenesis

  2000cited by this paper
• RANK is essential for osteoclast and lymph node development.

  1999cited by this paper
• Therapeutic antibodies elicited by immunization against TNF-α

  1999cited by this paper
• B cell memory and the long-lived plasma cell.

  1999cited by this paper
• TRANCE, a Tumor Necrosis Factor Family Member Critical for CD40 Ligand–independent T Helper Cell Activation

  1999cited by this paper
• OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis

  1999cited by this paper
• Osteoprotegerin Is a Receptor for the Cytotoxic Ligand TRAIL*

  1998influential reference
• Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation.

  1998cited by this paper
• TRANCE Is a Novel Ligand of the Tumor Necrosis Factor Receptor Family That Activates c-Jun N-terminal Kinase in T Cells*

  1997cited by this paper
• A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function

  1997cited by this paper
• Osteoprotegerin: a novel secreted protein involved in the regulation of bone density.

  1997cited by this paper
• Neutralizing antiviral B cell responses.

  1997cited by this paper
• Identification and characterization of a new member of the TNF family that induces apoptosis.

  1995cited by this paper
• Regulation of IgG antibody titers by the amount persisting of immune‐complexed antigen

  1994cited by this paper
• The influence of antigen organization on B cell responsiveness.

  1993cited by this paper
• The Maintenance and Regulation of the Humoral Immune Response: Persisting Antigen and the Role of Follicular Antigen‐Binding Dendritic Cells as Accessory Cells

  1980cited by this paper

• Obesity- and age-dependent genetic regulation of the plasma proteome in children and adolescents

  2025cites this paper
• Blackcurrants shape gut microbiota profile and reduce risk of postmenopausal osteoporosis via the gut-bone axis: Evidence from a pilot randomized controlled trial.

  2024cites this paper
• Structural basis of epitope recognition by anti-alpha-synuclein antibodies MJFR14-6-4-2

  2023cites this paper
• A novel modified RANKL variant can prevent osteoporosis by acting as a vaccine and an inhibitor

  2021cites this paper
• Vaccine of RANKL mutant conjugated with KLH effectively stabilizing bone metabolism and preventing trabecular microstructural degeneration in osteoporotic rats

  2020cites this paper
• Virus-Like Particles as an Immunogenic Platform for Cancer Vaccines

  2020cites this paper
• Modification of the RANKL-RANK-binding site for the immunotherapeutic treatment of osteoporosis

  2019cites this paper
• 41 – Noninfectious Disease Vaccines

  2018cites this paper
• A new vaccine targeting RANKL, prepared by incorporation of an unnatural Amino acid into RANKL, prevents OVX-induced bone loss in mice.

  2018cites this paper
• A novel recombinant RANKL vaccine prepared by incorporation of an unnatural amino acid into RANKL and its preventive effect in a murine model of collagen‐induced arthritis

  2018cites this paper
• Development of Autologous C5 Vaccine Nanoparticles to Reduce Intravascular Hemolysis in Vivo.

  2017cites this paper
• The True Story and Advantages of RNA Phage Capsids as Nanotools

  2016cites this paper
• Virus-based nanoparticles as platform technologies for modern vaccines.

  2016cites this paper
• OSTEOPOROSIS AND PERIODONTAL DISEASE: ASSOCIATION AND MECHANISMS: AN IN-DEPTH REVIEW

  2016cites this paper
• Osteoporosis and Periodontal Disease: Association and Mechanisms

  2016cites this paper
• The application of virus-like particles as vaccines and biological vehicles

  2015cites this paper
• A RANKL mutant used as an inter-species vaccine for efficient immunotherapy of osteoporosis

  2015cites this paper
• 54 – Noninfectious disease vaccines

  2013cites this paper
• Enhanced Neutralizing Antibody Titers and Th1 Polarization from a Novel Escherichia coli Derived Pandemic Influenza Vaccine

  2013cites this paper
• from Arthritis without Inducing Reactivation Protects α Selectively Targeting Soluble TNF- A Virus-Like Particle-Based Vaccine

  2013cites this paper
• Development of Virus-Like Particle Technology from Small Highly Symmetric to Large Complex Virus-Like Particle Structures

  2013cites this paper
• Virus-Like Particles as Efficient Delivery Platform to Induce a Potent Immune Response

  2012cites this paper
• Follicular dendritic cells in health and disease

  2012cites this paper
• Peptides: an arrival point in cancer vaccinology.

  2012cites this paper
• Virus like particle based strategy to elicit HIV-protective antibodies to the alpha-helic regions of gp41.

  2012cites this paper
• Innovation in Vaccinology

  2012cites this paper
• Design and Development of Recombinant Vaccines with Viral Properties

  2011cites this paper
• Therapeutic vaccines for chronic diseases: successes and technical challenges

  2011cites this paper
• Induction of mucosal immunity using virus-like particle based vaccines

  2011cites this paper
• Kinoids: a family of immunogens for active anticytokine immunotherapy applied to autoimmune diseases and cancer.

  2010cites this paper
• Combined vaccination against IL-5 and eotaxin blocks eosinophilia in mice.

  2010cites this paper
• Carrier induced epitopic suppression of antibody responses induced by virus-like particles is a dynamic phenomenon caused by carrier-specific antibodies.

  2010cites this paper
• Versatile Virus-Like Particle Carrier for Epitope Based Vaccines

  2010cites this paper
• A VLP-based vaccine targeting domain III of the West Nile virus E protein protects from lethal infection in mice

  2010cites this paper
• Immunodrugs: breaking B- but not T-cell tolerance with therapeutic anticytokine vaccines.

  2010cites this paper
• Displaying Fel d1 on virus-like particles prevents reactogenicity despite greatly enhanced immunogenicity: a novel therapy for cat allergy

  2009cites this paper
• Immunodrugs: therapeutic VLP-based vaccines for chronic diseases.

  2009cites this paper
• RANKLinhibitionforthe managementofpatientswith benignmetabolicbonedisorders

  2009cites this paper
• RANKL inhibition for the management of patients with benign metabolic bone disorders

  2009cites this paper
• The coming of age of virus-like particle vaccines

  2008cites this paper
• Novel anti-cancer strategy in bone tumors by targeting molecular and cellular modulators of bone resorption.

  2008cites this paper
• Pattern recognition by B cells: the role of antigen repetitiveness versus Toll-like receptors.

  2008cites this paper
• Exploiting viral properties for the rational design of modern vaccines

  2008cites this paper
• Mucosal and systemic antibody responses induced by virus-like particles

  2008cites this paper
• Novel Anti-Cancer Strategy in Bone Tumors by Targeting Molecular and Cellular Modulators of Bone Resorption

  2008cites this paper
• Strategies for novel therapeutic approaches targeting cytokines and signaling pathways of osteoclasto- and osteoblastogenesis in the fight against immune-mediated bone and joint diseases.

  2008cites this paper
• Immunogenic display of diverse peptides on virus-like particles of RNA phage MS2.

  2008cites this paper
• Vaccination against GIP for the Treatment of Obesity

  2008cites this paper
• Active immunization against macrophage migration inhibitory factor using a novel DNA vaccine prevents ovariectomy-induced bone loss in mice.

  2008cites this paper
• Efficient induction of mucosal and systemic immune responses by virus‐like particles administered intranasally: implications for vaccine design

  2008cites this paper
• Emerging applications of anticytokine vaccines

  2008cites this paper
• Active immunization with IL‐1 displayed on virus‐like particles protects from autoimmune arthritis

  2008cites this paper
• The renin-angiotensin system and therapeutic vaccines for hypertension.

  2008cites this paper
• Receptor activator of nuclear factor kappaB ligand and osteoprotegerin regulation of bone remodeling in health and disease.

  2008cites this paper
• Modèle animal de perte osseuse

  2007cites this paper
• A novel DNA vaccine targeting macrophage migration inhibitory factor protects joints from inflammation and destruction in murine models of arthritis.

  2007cites this paper
• Virus-like particles: flexible platforms for vaccine development

  2007cites this paper
• Targeting osteoporosis and rheumatoid arthritis by active vaccination against RANKL.

  2007cites this paper
• Osteoclastogénesis y enfermedades óseas

  2007cites this paper
• OSTEOCLASTOGENESIS AND BONE DISEASES

  2007cites this paper
• A Virus-Like Particle-Based Vaccine Selectively Targeting Soluble TNF-α Protects from Arthritis without Inducing Reactivation of Latent Tuberculosis

  2007cites this paper
• A second vaccine revolution for the new epidemics of the 21st century.

  2006cites this paper
• Neutralization of IL‐17 by active vaccination inhibits IL‐23‐dependent autoimmune myocarditis

  2006cites this paper
• Neue pathophysiologische Stoffwechselwege in der Osteoporose

  2006cites this paper
• Vaccination against IL‐17 suppresses autoimmune arthritis and encephalomyelitis

  2006cites this paper
• [New pathophysological relevant metabolic pathways in osteoporosis. Future innovative therapies?].

  2006cites this paper
• Osteoclasts, rheumatoid arthritis, and osteoimmunology

  2006cites this paper
• Clinical and basic research papers – October 2005 selections

  2005cites this paper